The Lancet RSS feed. The Lancet is the world's leading independent general medical journal. The journal's coverage is international in focus and extends to all aspects of human health. The Lancet publishes the original primary research and review art
1k followers 18 articles/week
[Articles] Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)

Early intensive glycaemic control with sulfonylurea or insulin, or with metformin, compared with conventional glycaemic control, appears to confer a near-lifelong reduced risk of death and myocardial infarction. Achieving near normoglycaemia immediately following diagnosis might be essential to minimise the lifetime risk of diabetes-related complications...

Sat May 18, 2024 09:21
[World Report] Humanitarian funding shortages hit Syria

A lack of funds is compounding attacks on health care, for which no one has yet been held to account. By Sharmila Devi.

Sat May 18, 2024 01:30
[Comment] Inflammatory bowel disease has no borders: engaging patients as partners to deliver global, equitable and holistic health care

World inflammatory bowel disease (IBD) Day 2024 unites around the theme IBD has no borders. As a multinational authorship of physicians and people with lived experiences of IBD, we recognise that Crohn's disease and ulcerative colitis extend across both geographical and personal boundaries. Traditionally considered to be a disease of high-income countries...

Sat May 18, 2024 01:30
[World Report] Canada's family physician shortage

Increasing numbers of doctors are leaving the specialty or switching to private practice, leaving millions without effective primary care. Paul Webster reports.

Sat May 18, 2024 01:30
[Articles] Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

There was no benefit and possible harm from treatment with intravenous tenecteplase. Patients with minor stroke and intracranial occlusion should not be routinely treated with intravenous thrombolysis.

Fri May 17, 2024 12:14
[Comment] Advances and challenges in the acute treatment of minor ischaemic stroke

Although characterised by mild neurological symptoms, typically ranging from 0 to 5 on the National Institutes of Health Stroke Scale (NIHSS), minor ischaemic stroke is associated with frequent long-term disability and a significant risk of stroke recurrence.1 Research on the treatment of minor stroke has progressed along two parallel paths: acute revascularisation2–4...

Fri May 17, 2024 12:14

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account